Search
BioNTech Founders to Depart and Establish New mRNA Enterprise
13 hour ago /
Read about 0 minute
Author：小编
On March 10, 2026, local time, Germany's BioNTech announced that its co-founders, Ugur Sahin and Özlem Türeci, will leave the company by the end of the year to jointly establish a new company focused on the innovative research and development of next-generation mRNA technology. BioNTech will transfer relevant intellectual property rights and technology platforms to the new company, hold a minority stake, and receive milestone payments as well as a share of future product sales. This move aims to accelerate the translation of cutting-edge mRNA technology and strengthen its global innovation footprint.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
